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A B S T R A C T
A human induced pluripotent stem cell (iPSC) line was generated from fibroblasts of a patient with propionic acidemia that has a homozygous mutation
(c.1218_1231del14ins12 (p.G407 fs)) in the PCCB gene. Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC were delivered using a non-integrative method
based on the Sendai virus. Once established, iPSCs have shown full pluripotency, differentiation capacity and genetic stability. The generated iPSC line represents a
useful tool to study the pathomechanisms underlying the deficiency.
Resource table.
Unique stem cell lines
identifier
UAMi004-A
Alternative name of st-
em cell line
PCCB10-FiPS4F-1
Institution Centro de Biología Molecular Severo Ochoa UAM-CSIC,
Universidad Autónoma de Madrid, CIBERER, IDIPaz,
Madrid, Spain.
Contact information of
distributor
Eva Richard, erichard@cbm.csic.es
Type of cell line iPSC
Origin Human
Additional origin info Age: 30
Sex: Female
Ethnicity if known: Caucasian
Cell Source Fibroblasts
Clonality Clonal
Method of reprogram-
ming
Sendai Virus
Genetic modification Yes
Type of modification Hereditary
Associated disease Propionic acidemia
Gene/locus PCCB / 3q22
Method of modification Non applicable
Name of transgene or
resistance
Non applicable
Inducible/constitutive
system
Non applicable
Date archived/stock d-
ate
March 2019
Cell line repository/ba-
nk
Spanish National Bank of Cell Lines http://www.isciii.es/
ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-
estructura-directiva/fd-subdireccion-general-
investigacion-terapia-celular-medicina-regenerativa/fd-
centros-unidades/fd-banco-nacional-lineas-celulares/fd-
lineas-celulares-disponibles/lineas-de-celulas-iPS.shtml
Ethical approval Patient informed consent obtained.
Ethics Review Board-competent authority approval ob-
tained (CEI 71–1278)
1. Resource utility
The pathophysiology of propionic acidemia is not completely un-
derstood and its treatment currently is not satisfactory. In order to in-
vestigate underlying cellular pathological mechanisms and to test po-
tential therapeutic compounds, we have established an iPSC line with a
homozygous mutation in the PCCB gene.
2. Resource details
Propionic acidemia (PA, MIM#606054, ORPHA:35) is one of the
most frequent life-threatening organic acidemias, caused by mutations
https://doi.org/10.1016/j.scr.2019.101469
Received 23 April 2019; Received in revised form 16 May 2019; Accepted 20 May 2019
⁎ Corresponding author at: Centro de Biología Molecular Severo Ochoa UAM-CSIC, Nicolás Cabrera 1, Universidad Autónoma Madrid, 28049 Madrid, Spain.
E-mail address: erichard@cbm.csic.es (E. Richard).
Stem Cell Research 38 (2019) 101469
Available online 22 May 2019
1873-5061/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
Fig. 1. Characterization of the iPSC line PCCB10-FiPS4F1 (UAMi004-A).
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in either the PCCA or PCCB genes, encoding both subunits of the mi-
tochondrial propionyl-CoA carboxylase (PCC) enzyme, that catalyzes
the carboxylation of propionyl-CoA to D-methylmalonyl-CoA, which
eventually enters the Krebs cycle as succinyl-CoA (Richard et al., 2015).
Fibroblasts from a homozygous PA patient carrying the previously de-
scribed c.1218_1231del14ins12 (p.G407 fs) mutation in the PCCB gene
(Tahara et al., 1990) were reprogrammed using the CytoTune™ iPS
Reprogramming kit delivering the four human reprogramming factors
OCT3/4, SOX2, c-MYC and KLF4 (Takahashi et al., 2007). The iPSC line
PCCB10-FiPS4F1 (UAMi004-A) (PCCB10–1 in figures for short) dis-
played a typical round shape ESC-like morphology and growth beha-
viour on feeder layers and on feeder-free layers (Fig. 1A, Table 1).
Clearance of the vectors and of the exogenous reprogramming factor
genes was observed by RT-PCR after 8 culture passages (Fig. 1B). Ex-
pression of key pluripotency genes was observed at protein level by
immunocytochemistry (transcription factors OCT4, NANOG and SOX2,
and surface markers SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81) (Fig. 1C,
Table 1) and flow cytometry analysis (Fig. 1D, Table 1). The iPSC line
displayed a normal karyotype (46, XX) after more than twenty culture
passages (Fig. 1E). The cells had the capacity to form derivatives of all
three germ layers (endoderm, mesoderm and ectoderm) upon embryoid
body differentiation (Fig. 1F, Table 1). Mycoplasma testing by PCR
revealed a negative result (Supplementary Fig. S1A). We confirmed the
presence of the mutation in the iPSC line in homozygous fashion by
Sanger sequencing (Supplementary Fig. S1B); and we also confirmed by
DNA fingerprinting analysis that the line was derived from the patient
fibroblasts.
3. Materials and methods
3.1. Non-integrative reprogramming of mutant PCCB fibroblasts into iPSC
The present study included available fibroblasts from a PA patient
with defects in the PCCB gene. Experimental protocols were approved
by the Institutional Ethical Committee of the Universidad Autónoma de
Madrid according to Spanish and European Union legislation, and the
informed consent was obtained from the legal care-givers. Fibroblasts
were reprogrammed using the CytoTune™ iPS Reprogramming kit
(ThermoFisher Scientific) following the manufacturer's instructions.
iPSCs were maintained and expanded both on feeder layers and on
feeder-free layers as previously described (Alonso-Barroso et al., 2017).
3.2. Detection of Sendai virus genome and transgenes
After 8 passages, iPSC line was tested for Sendai virus (SeV) residues
as described (Alonso-Barroso et al., 2017). PCR was performed using
the primers indicated in Table 2 and following the instructions as
recommended by the manufacturer. In Fig. 1 panel B: C+: transduced
cell pool at passage zero; C–: non-template control.
3.3. Immunofluorescence analysis
iPSC were grown on feeder-free layers on 15 μ-Slide 8 well culture
plates (Ibidi) and fixed with Formaline Solution 10% (Sigma-Aldrich).
Immunofluorescence analysis was performed as previously described
(Alonso-Barroso et al., 2017). In Fig. 1 scale bars: 100 μm.
3.4. Flow cytometry analysis
We analysed the pluripotency-associated markers SSEA-3 and SSEA-
4 by flow cytometry as described (Alonso-Barroso et al., 2017). Un-
stained iPSCs and the corresponding isotype antibodies were used as
negative controls to exclude data from non-specific fluorescence.
3.5. In vitro differentiation
iPSCs were detached with Accutase™ into a single cell suspension
and resuspended in mTESR™1 medium (StemCell™ Technologies) with
10 μM Rock inhibitor (StemCell™ Technologies). Embryoid body for-
mation was induced by seeding 20,000–30,000 iPS cells in 120 μl of
mTESR™1 medium in each well of 96-well v-bottom, low attachment
plates (Deltalab). In vitro differentiation was performed as described
(Alonso-Barroso et al., 2017).
3.6. Mycoplasma detection
Cells were screened for mycoplasma contamination by PCR (Uphoff
& Drexler, 2014). A positive sample with mycoplasma was used as a
control. In Supplementary Fig. S1A: positive control (C+).
3.7. Mutation analysis
Genomic DNA from patient-derived fibroblasts and iPSCs was iso-
lated using MagNA Pure Compact DNA Isolation kit and MagNA Pure
Compact instrument (Roche). Subsequently, amplification by PCR of
the PCCB region containing the mutation was carried out using the
primers indicated in Table 2, FastStart Taq DNA Polymerase (Roche),
the Veriti Thermal Cycler (ThermoFisher Scientific) and the PCR pro-
gram: 94 °C 5min; 94 °C 25 s, 55 °C 25 s and 72 °C 40 s for 38 cycles; and
72 °C 7min. Amplified PCR fragments were sequenced in an ABI3730
sequencer (Applied Biosystems).
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1 panel A
Phenotype Qualitative analysis
(Immunocytochemistry)
Positive for: OCT4, NANOG, SOX2, SSEA-3, TRA-1-81, SSEA-4 and
TRA-1-60
Fig. 1 panel C
Quantitative analysis (Flow cytometry) SSEA-3 and SSEA-4: 95% Fig. 1 panel D
Genotype Karyotype (G-banding) and resolution 46XX Resolution 450–500 Fig. 1 panel E
Identity STR analysis 16 sites tested and all of them matched Available with the authors
Mutation analysis (IF
APPLICABLE)
Sequencing c.1218_1231del14ins12 (p.G407fs) Supplementary Fig. S1 panel
B
Southern Blot OR WGS Not performed
Microbiology and virology Mycoplasma Mycoplasma testing by PCR: negative Supplementary Fig. S1 panel
A
Differentiation potential Embryoid body formation Expression of α-1-fetoprotein (endoderm), α-smooth muscle actin
(mesoderm) and β-III-tubulin Tuj1 (ectoderm)
Fig. 1 panel F
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C Not performed No
Genotype additional info
(OPTIONAL)
Blood group genotyping Not performed No
HLA tissue typing Not performed No
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3.8. Karyotype analysis
Karyotype analysis of the iPSC line was carried out using cells with
more than twenty culture passages which were processed using stan-
dard cytogenetic techniques as described (Alonso-Barroso et al., 2017).
At least 35 metaphases were karyotyped.
3.9. DNA fingerprinting analysis
DNA fingerprinting analysis was performed as previously described
(Alonso-Barroso et al., 2017).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2019.101469.
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Table 2
Reagents details.
Antibodies used for immunocytochemistry/flow-cytometry
Antibody Dilution Company Cat # and RRID
Pluripotency Markers Mouse IgG anti-OCT4 1:60 Santa Cruz Cat# sc-5279, AB_628051
Rat IgM anti-SSEA-3 1:3 Hybridoma Bank Cat# MC-631, AB_528476
Rabbit IgG anti-SOX2 1:100 Fisher Thermo Scientific Cat# PA1–16968, AB_2195781
Mouse IgG anti-SSEA-4 1:3 Hybridoma Bank Cat# MC-813-70, AB_528477
Mouse IgM anti-TRA-1-60 1:200 Millipore Cat# MAB4360, AB_2119183
Goat IgG anti-NANOG human 1:25 R&D Cat# AF1997, AB_355097
Mouse IgM anti-TRA-1-81 1:200 Millipore Cat# MAB4381, AB_177638
Differentiation Markers Rabbit IgG anti-α-Fetoprotein 1:400 Dako Cat# A0008, AB_2650473
Mouse IgG anti-β-III-Tubulin Tuj1 1:500 Covance Cat# MMS-435P, AB_231377
Mouse IgG anti-α-smooth muscle actin 1:400 Sigma-Aldrich Cat# A5228, AB_262054
Secondary antibodies Alexa 555 Donkey anti-Mouse IgG 1:200 Thermo Fischer Cat# A-31570, AB_2536180
Alexa 488 Goat anti-Rat IgM 1:200 Thermo Fischer Cat#A-21212, AB_2535798
Alexa 488 Donkey anti-Rabbit IgG 1:200 Thermo Fischer Cat# A-31572, AB_162543
Alexa 555 Donkey anti-Mouse IgG 1:200 Thermo Fischer Cat# A-31570, AB_2536180
Alexa 647 Goat anti-Mouse IgM 1:200 Thermo Fischer Cat# A-21238, AB_2535807
Alexa 647 Donkey anti-Goat IgG 1:200 Thermo Fischer Cat# A-21447, AB_2535864
Cy3 Donkey anti-Mouse IgM 1:200 Jackson Cat# 715-165-140, AB_2340812
Alexa 647 Goat anti-mouse IgG 1:600 Thermo Fischer Cat# A- 21235, AB_2535804
Alexa 647 Donkey anti-rat IgM 1:600 Thermo Fischer Cat# A-21248, AB_2535816
Primers
Target Forward/Reverse primer (5′-3′)
Reverse Transcription-PCR SeV genome (181 pb) GGATCACTAGGTGATATCGAGC/ ACCAGACAAGAGTTTAAGAGATATGTATC
KOS transgene (528 bp) ATGCACCGCTACGACGTGAGCGC/ ACCTTGACAATCCTGATGTGG
KLF4 transgene (410 bp) TTCCTGCATGCCAGAGGAGCCC/ AATGTATCGAAGGTGCTCAA
c-MYC transgene (532 bp) TAACTGACTAGCAGGCTTGTCG/ TCCACATACAGTCCTGGATGATGATG
Targeted mutation analysis/sequencing
(PCR)
PCCB-exons 11 and 12 (601 bp) GGATGGCTGCTGAGGACAAA/TCCCACCACGGCTATGCTGTAG
Mycoplasma detection (PCR) Mycoplasma species (986 bp: internal control band;
and 520 bp: mycoplasma specific band)
Forward primers:
CGCCTGAGTACGTTCGC
CGCCTGAGTACGTACGC
TGCCTGGGTAGTACATTCGC
TGCCTGAGTAGTACATTCGC
CGCCTGAGTAGTATGCTCGC
CACCTGAGTAGTATGCTCGC
CGCCTGGGTAGTACATTCGC
Reverse primers:
GCGGTGTGTACAAGACCCGA
GCGGTGTGTACAAAACCCGA
GCGGTGTGTACAAACCCCGA
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